[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Fundación Sociedad Española de Oncologia Médica\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":100},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,47,78],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100605866","trajectories-of-anxiety-and-depression-in-cancer-patients-risk-and-predictive-factors-and-supportive-care-prognostic-awareness-and-shared-decision-making-100605866",false,"NCT07168096","Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.","NEOPSYCO STUDY: Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.","Inclusion Criteria:\n\n* Histologically confirmed diagnosis of solid cancer (non-hematologic) at any stage.\n* Adult age (\\>18 years).\n* Candidate for perioperative systemic antineoplastic treatment or for advanced disease.\n* Willingness to participate in the study and sign the informed consent form, as appropriate, before initiating any study-specific procedures, in accordance with good clinical practice requirements and local regulations.\n\nExclusion Criteria:\n\n* Presence of a pre-existing psychiatric or neurodegenerative disorder that impairs the patient's ability to participate in the study.\n* Presence of reading and writing difficulties that prevent the patient from completing the assessments.\n* Receipt of oncological treatment in the past 2 years for another cancer.","ALL","18 Years",{"count":19,"type":20},540,"ESTIMATED","2 Years","OBSERVATIONAL","To examine the trajectories of anxiety and depression symptoms over the course of oncological disease, and to assess potential predictors-sociodemographic (age, sex, marital status, employment status), clinical (tumor location, stage, treatment type, general health), psychological (coping strategies, quality of life, cognitive difficulties, fear of recurrence), and physical activity-and their association with support needs and utilization of psychosocial services.",[25,26,27],"Depression","Cancer","Anxiety",[29,30,31,32,33],"anxiety","cancer","depression","quality of life","cognitive difficulties","RECRUITING","2025-09-10",{"date":37,"type":38},"2025-09-11","ACTUAL",{"date":40,"type":38},"2024-09-12",{"date":42,"type":20},"2027-12",{"name":44,"class":45},"Fundación Sociedad Española de Oncologia Médica","OTHER",18,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},"100436091","spanish-registry-of-esophagogastric-cancer-100436091","NCT04958720","Spanish Registry of Esophagogastric Cancer","AGAMENON-SEOM Study: Spanish Registry of Esophagogastric Cancer","AGAMENON","Inclusion Criteria:\n\n* Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown).\n* Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause.\n\nExclusion Criteria:\n\n* A patient for whom, for whatever reason, the information necessary to complete the database cannot be known or obtained.","100 Years",{"count":57,"type":20},10000,"This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach cancer in order to optimize the management, treatment and evolution of patients, the possibility of comparing variables with those of other series or groups, and promotes the quality of scientific publications.",[60,61],"Esophageal Cancer","Gastric Cancer",[61,63,60,64,65,66,67,68],"Gastroesophageal junction cancer","Surgery","Chemotherapy","Radiotherapy","Antitargeted drug","Inmunotherapy","2025-06-30",{"date":71,"type":38},"2025-07-03",{"date":73,"type":38},"2020-04-27",{"date":75,"type":20},"2035-12-01",{"name":44,"class":45},38,{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":86,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":88,"conditions":89,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},"100351419","registry-of-thrombosis--neoplasia-of-sociedad-espaola-de-oncologa-mdica-100351419","NCT03855592","Registry of Thrombosis & NEoplasia of \"Sociedad Española de Oncología Médica\"","Observational Epidemiological Study of Cancer-associated Thrombosis: Registry of Thrombosis & NEoplasia of SEOM (TESEO Study)","TESEO","Inclusion Criteria:\n\n* Over 18 years of age with a histologically confirmed diagnosis of malignant tumor.\n* Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc.\n* Signing of informed consent.\n\nExclusion Criteria:\n\n* Clinical diagnosis of thromboembolic event without radiological confirmation.\n* Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event.\n* Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.",{"count":87,"type":20},700,"Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a month prior to cancer diagnosis or at anytime after such diagnosis",[90,26],"Thromboembolism","2025-05-13",{"date":93,"type":38},"2025-05-16",{"date":95,"type":38},"2018-07-04",{"date":97,"type":20},"2026-07",{"name":44,"class":45},48,""]